September 14, 2018

New Lilly Diabetes Center of Excellence Established at the Indiana Biosciences Research Institute

INDIANAPOLIS, September 13, 2018 - Eli Lilly and Company (NYSE: LLY) and the Indiana Biosciences Research Institute (IBRI), in collaboration with Indiana University School of Medicine, have created the Lilly...

September 13, 2018

Veteran entrepreneurial leader named Purdue Research Foundation’s chief innovation and collaboration officer

WEST LAFAYETTE, Ind. -- Purdue University President Mitch Daniels and Purdue Research Foundation President Brian Edelman have jointly announced the appointment of David Broecker as the foundation's chief innovation and...

June 07, 2018

Purdue University expands partnership with Indiana Biosciences Research Institute

Purdue University and the Indiana Biosciences Research Institute (IBRI) have entered into a strategic alliance agreement that allows for seamless research interactions among researchers at both institutions. The governance...

May 29, 2018

Indiana Biosciences Research Institute Names Vice President for Advancement

The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Stephanie Grinage as vice president for Advancement. As IBRI’s top development officer, she will serve as the primary strategic...

May 16, 2018

Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs

The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs, effective April 23, 2018. In this role,...

April 30, 2018

Zorion Medical Opens New Lab

Zorion Medical, Inc. has leased lab and production space in Indianapolis to jumpstart the development and clinical scale manufacturing of its fully absorbable medical device technology. The company is the...

April 20, 2018

John C. Lechleiter appointed to Indiana Biosciences Research Institute board of directors

The Indiana Biosciences Research Institute (IBRI) announces former Eli Lilly and Company chairman, president and CEO John C. Lechleiter, Ph.D., has joined its board of directors. Dr. Lechleiter retired from...

January 03, 2018

Indiana Biosciences Research Institute Names Lilly Executive Jay McGill Chief Operating Officer

Indianapolis, January 3, 2017 – The Indiana Biosciences Research Institute (IBRI) today announced that Jay McGill, Ph.D., has been named chief operating officer. McGill formerly spent 28 years at Eli...

September 07, 2017

Indiana Biosciences Research Institute, Indiana-based Universities Partner to Unlock Life Sciences Discoveries

The Indiana Biosciences Research Institute (IBRI) has partnered with four Indiana universities to license available life sciences technologies at pre-defined terms. Ball State University, Indiana University, Purdue University, and the...

August 31, 2017

Indiana Biosciences Research Institute Names Dr. Rainer Fischer CEO

The Indiana Biosciences Research Institute (IBRI) today announced that it has named current Chief Scientific and Innovation Officer Rainer Fischer, Ph.D., as Chief Executive Officer alongside his current role, effective...

First ... 6 7 8 9 10  ... Last 
2019 Annual Report cover

The IBRI 2019 Annual Report is now available. The report theme is “Catalyze, Complement, Connect,” which correlates with the IBRI's goals to seek solutions for health problems, enhance the Indiana life sciences ecosystem, and expedite solutions for the most pressing health issues.